Shanghai Pharmaceuticals Holding Co.,Ltd.’s Net Profit Dropped 25.1% in First Half of 2023

Shanghai Pharmaceuticals Holding Co.,Ltd. (上海医药集团股份有限公司) (601607.SH) reported a net profit of 3.4 billion yuan in the first half of 2023, down 25.1% year-on-year.

Meanwhile, the company posted 132.6 billion yuan in revenue, up 18.7% year-on-year.

At the end of the reporting period, it had 213.3 billion yuan in total assets and 134.4 billion yuan in total liabilities, with a liability-to-asset ratio of 63%.